IL87678A - N-methylene-2,3 -cycloalkylene- (and 2,3-heteroalkylene) -4-quinolinamines, a process for their preparation and pharmaceutical compositions containing them - Google Patents

N-methylene-2,3 -cycloalkylene- (and 2,3-heteroalkylene) -4-quinolinamines, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL87678A
IL87678A IL87678A IL8767888A IL87678A IL 87678 A IL87678 A IL 87678A IL 87678 A IL87678 A IL 87678A IL 8767888 A IL8767888 A IL 8767888A IL 87678 A IL87678 A IL 87678A
Authority
IL
Israel
Prior art keywords
quinolinamines
heteroalkylene
cycloalkylene
methylene
preparation
Prior art date
Application number
IL87678A
Other languages
English (en)
Other versions
IL87678A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL87678A0 publication Critical patent/IL87678A0/xx
Publication of IL87678A publication Critical patent/IL87678A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL87678A 1987-09-08 1988-09-06 N-methylene-2,3 -cycloalkylene- (and 2,3-heteroalkylene) -4-quinolinamines, a process for their preparation and pharmaceutical compositions containing them IL87678A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9418187A 1987-09-08 1987-09-08
US22384888A 1988-07-25 1988-07-25

Publications (2)

Publication Number Publication Date
IL87678A0 IL87678A0 (en) 1989-02-28
IL87678A true IL87678A (en) 1993-03-15

Family

ID=26788584

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87678A IL87678A (en) 1987-09-08 1988-09-06 N-methylene-2,3 -cycloalkylene- (and 2,3-heteroalkylene) -4-quinolinamines, a process for their preparation and pharmaceutical compositions containing them

Country Status (11)

Country Link
EP (1) EP0306826A1 (ja)
JP (1) JPH01131161A (ja)
KR (1) KR890005059A (ja)
AU (1) AU609872B2 (ja)
DK (1) DK497788A (ja)
FI (1) FI884105A (ja)
HU (1) HU203536B (ja)
IL (1) IL87678A (ja)
NO (1) NO883987L (ja)
NZ (1) NZ226055A (ja)
PT (1) PT88443B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175172A (en) * 1988-12-19 1992-12-29 Francois Dietlin Method of alleviating AIDS symptoms and compositions therefor
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE63903T1 (de) * 1984-10-25 1991-06-15 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.

Also Published As

Publication number Publication date
KR890005059A (ko) 1989-05-11
FI884105A (fi) 1989-03-09
NZ226055A (en) 1991-08-27
NO883987L (no) 1989-03-09
IL87678A0 (en) 1989-02-28
HUT49333A (en) 1989-09-28
DK497788D0 (da) 1988-09-07
PT88443A (pt) 1989-07-31
FI884105A0 (fi) 1988-09-06
NO883987D0 (no) 1988-09-07
JPH01131161A (ja) 1989-05-24
DK497788A (da) 1989-03-09
EP0306826A1 (en) 1989-03-15
PT88443B (pt) 1992-10-30
HU203536B (en) 1991-08-28
AU609872B2 (en) 1991-05-09
AU2193588A (en) 1989-03-09

Similar Documents

Publication Publication Date Title
IL85741A0 (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and pharmaceutical compositions containing them
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
IL88670A0 (en) 2,5-diaryl-tetrahydrofurans and analogs thereof and pharmaceutical compositions containing them
IL86798A0 (en) 2,2-dimethylchroman-3-ol derivatives,their preparation and pharmaceutical compositions containing them
HUT48248A (en) Process for producing 3,7-diazabicyclo/3,3,1/-nonan derivatives and pharmaceutical compositions containing them
IL84841A (en) 2,3-disubstituted isoxazolidines,a process for their preparation,and pharmaceutical compositions containing them
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
HUT50121A (en) Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them
EP0251453A3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
IL86027A (en) 2-acylpyrrolidine derivatives,a process for the preparation thereof,compositions containing them,and their use
HUT46303A (en) Process for producing 3-/omega-/3,5-di-/tetrabutil/-4-hydroxy-phenyl/-alkanoyl/-pyrroles andtheyr deoxy-analogues and pharmaceutical compositions containing them
IL88002A0 (en) 2,2-dimethylchromene derivatives,their preparation and pharmaceutical compositions containing them
EP0236929A3 (en) 1,2-dithiol-3-thione derivatives, a process for preparing them and a pharmaceutical composition containing them
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
PH18051A (en) 3,4-bis-substituted 1,2,5-oxdiazole 2-oxides,a process for their preparation,and pharmaceutical formulations containing them
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
IL87912A0 (en) Renin-inhibiting dipeptides,a process for the preparation thereof and pharmaceutical compositions containing them
IL87679A0 (en) (substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines,a process for their preparation and pharmaceutical compositions containing same
DE3568041D1 (en) Sulfonamidines, a process for preparing them and pharmaceutical compositions containing them
ZA851547B (en) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines,a process for their preparation and pharmaceutical products containing these compounds
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL90219A0 (en) Hydrazinocarbonyloxylabdanes,a process for their preparation and pharmaceutical compositions containing them
IL87678A (en) N-methylene-2,3 -cycloalkylene- (and 2,3-heteroalkylene) -4-quinolinamines, a process for their preparation and pharmaceutical compositions containing them
IL92289A0 (en) 1-aminoalkyl-3-oxysubstituted 4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepine-2-ones,a process for their preparation and pharmaceutical compositions containing them